[Federal Register Volume 79, Number 81 (Monday, April 28, 2014)]
[Notices]
[Page 23376]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2014-09553]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Bulk Manufacturer of Controlled Substances Application: Organix, 
Inc.

ACTION: Notice of application with opportunity for comment.

-----------------------------------------------------------------------

DATES: Registered bulk manufacturers of the affected basic classes and 
applicants therefore may file written comments or objections to the 
issuance of the proposed registration in accordance with 21 CFR 
1301.33(a) on or before June 27, 2014.

ADDRESSES: Written comments should be sent via regular or express mail 
to: Drug Enforcement Administration, Attention: DEA Federal Register 
Representative/ODW, 8701 Morrissette Drive, Springfield, Virginia 
22152.

SUPPLEMENTARY INFORMATION: The Attorney General has delegated his 
authority under the Controlled Substances Act to the Administrator of 
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority 
to exercise all necessary functions with respect to the promulgation 
and implementation of 21 CFR part 1301, incident to the registration of 
manufacturers, distributors, and dispensers of controlled substances 
(other than final orders in connection with suspension, denial, or 
revocation of registration) has been re-delegated to the Deputy 
Assistant Administrator of the DEA Office of Diversion Control 
(``Deputy Assistant Administrator'') pursuant to sec. 7(g) of 28 CFR 
part 0, subpart R, App.
    In accordance with 21 CFR 1301.33(a), this is notice that on 
February 3, 2014, Organix, Inc., 240 Salem Street, Woburn, 
Massachusetts 01801, made application by written correspondence to the 
DEA to be registered as a bulk manufacturer of the following basic 
classes of narcotic and nonnarcotic controlled substances:

------------------------------------------------------------------------
                                                          Narcotic/
       Controlled substance            Schedule          Nonnarcotic
------------------------------------------------------------------------
Gamma Hydroxybutyric Acid (2010).  I...............  nonnarcotic
Lysergic acid diethylamide (7315)  I...............  nonnarcotic
Heroin (9200)....................  I...............  narcotic
Morphine (9300)..................  II..............  narcotic
------------------------------------------------------------------------

    The company plans to manufacture reference standards for 
distribution to its research and forensics customers.

    Dated: April 21, 2014.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
[FR Doc. 2014-09553 Filed 4-25-14; 8:45 am]
BILLING CODE 4410-09-P